BS
LinkedIn

Björn Stollenwerk

Director, Product Lead LUMAKRAS, Xaluritamig, AMG 193, HEOR, Global Value & Access

Zug, Zug, Switzerland · 1 connection

Amgen

Not on Unlinked · Imported profile. Is this you? Claim it

About

Director Health Economics bei Amgen (Europe) GmbH

Experience

Director, Product Lead Sotorasib (LUMAKRAS/LUMYKRAS), HEOR, Global Value & AccessAmgen
Nov 2021
Director, TA Lead Solid Tumors, Economic Modeling, HEOR, Global Value & AccessAmgen
Jun 2021 to Oct 2021
Director, TA Lead Solid Tumors, Economic Modeling CoE, PACE (Pricing & Access CoE)Amgen
Feb 2021 to May 2021
Director, TA Lead General Medicine, Economic Modeling CoE, PACE (Pricing & Access CoE)Amgen
Sep 2020 to Jan 2021
Director, TA Lead Cardio/Bone/Metabolic, Economic Modeling CoE, GHEAmgen
Nov 2018 to Aug 2020
Director, TA Lead Bone/Nephrology/Inflammation (BONITA) & Biosimilars, Economic Modeling CoE, GHEAmgen
Jun 2018 to Oct 2018
Senior Manager, Product Lead Parsabiv, Mimpara, Prolia, Economic Modeling CoE, GHEAmgen
Jul 2014 to May 2018
Senior Health EconomistHelmholtz Munich
May 2008 to Jun 2014
Statistician / Health EconomistUniversity of Cologne Basic company page — company details not listed yet
Jun 2003 to Dec 2006

Education

Ludwig-Maximilians-Universität München
Habilitation (Dr. habil. med., Berufung zum Privatdozenten), Gesundheitsökonomie
2013 to 2013
TU Dortmund University
Promotion (Dr. rer. nat.), Statistik
2003 to 2006
TU Dortmund University
Dipl.-Stat., Statistik
1998 to 2003